June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Dry eye disease and meibomian gland dysfunction after allogeneic hematopoietic stem cell transplantation.
Author Affiliations & Notes
  • Marília Menezes Trindade Menezes Trindade Ferrer
    Oftalmo-Otorrinolaringologia, Unicamp, Campinas, SP, Brazil
  • Melina Rodrigues
    Onco-Hematologia, Unicamp, Campinas, Brazil
  • Bruna Duarte Moron de Andrade
    Oftalmo-Otorrinolaringologia, Unicamp, Campinas, SP, Brazil
  • Bruna Martins
    Oftalmo-Otorrinolaringologia, Unicamp, Campinas, SP, Brazil
  • Francisco Aranha
    Onco-Hematologia, Unicamp, Campinas, Brazil
  • Denise Oliveira
    Oftalmo-Otorrinolaringologia, Unicamp, Campinas, SP, Brazil
  • Eliana Miranda
    Onco-Hematologia, Unicamp, Campinas, Brazil
  • Marcos Colella
    Onco-Hematologia, Unicamp, Campinas, Brazil
  • Afonso Vigorito
    Onco-Hematologia, Unicamp, Campinas, Brazil
  • Monica Alves
    Oftalmo-Otorrinolaringologia, Unicamp, Campinas, SP, Brazil
  • Footnotes
    Commercial Relationships   Marília Menezes Trindade Ferrer, None; Melina Rodrigues, None; Bruna Duarte Moron de Andrade, None; Bruna Martins, None; Francisco Aranha, None; Denise Oliveira, None; Eliana Miranda, None; Marcos Colella, None; Afonso Vigorito, None; Monica Alves, None
  • Footnotes
    Support  Financial Support: Fapesp grant#2014/19138-5
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 4391. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Marília Menezes Trindade Menezes Trindade Ferrer, Melina Rodrigues, Bruna Duarte Moron de Andrade, Bruna Martins, Francisco Aranha, Denise Oliveira, Eliana Miranda, Marcos Colella, Afonso Vigorito, Monica Alves; Dry eye disease and meibomian gland dysfunction after allogeneic hematopoietic stem cell transplantation.. Invest. Ophthalmol. Vis. Sci. 2017;58(8):4391.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Cross-sectional study to (1) describe incidence, clinical features and outcome of dry eye disease (DED) and meibomian gland dysfunction (MGD) associated with ocular graft-versus-host disease (oGVHD) in allogeneic hematopoietic stem cell transplantation (allo-HSCT) patients and (2) show the experience of the recently created oGVHD Unit.

Methods : At the University of Campinas oGVHD Unit, ophthalmologists and hematologists have evaluated together all patients prior to transplantation procedure, during the follow-up or due to ocular discomfort any time after allo-HSCT. Patients were diagnosed with cGVHD per NIH Consensus criteria. The ancillary ophthalmological examination, including Schirmer's test, Ocular Surface Disease Index (OSDI), Corneal fluorescein staining (CFS), Conjunctival hyperemia (CH), Non-invasiveTear Breakup time (NITBUT) and Meibomian Gland Dysfunction (MGD) were compared to NIH ocular score at the onset of the ocular symptoms. Clinical and ocular surface data were analysed using descriptive tools and Pearson’s test using SPSS 21 version software.

Results : cGVHD occurred in 82% of 50 allo-HSCT patients (age 54.6±8.8 yo). The median month of cGVHD onset was 7 (2-74). The median of organs involved was 3 (1-6). Mouth, skin and liver were the main organs involved (93%, 63% and 63%, respectively). The ocular involvement was present in 54% of cGVHD patients. Comparing all cGVHD, with or without ocular involvement, Schirmer < 10mm (67% p<0.0001), CH > 1 (67% p<0.0001), CSF > 1 (43% p=0.005), and OSDI > 20 (65% p<0.0001) had a significant association with oGVHD. MGD was a common finding prior to allo-HSCT.

Conclusions : By evaluating patients at oGVHD Unit we have perceived that ocular surface dysfunction is present even before the HSCT and that oGVHD diagnosis remains a challenge. Schirmer’s test, CH, CFS and OSDI might be important tools to refine the evaluation of oGVHD and should be considered in clinical trials addressing ocular involvement.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×